-
Luye Pharma’s Boan Biotechnology Partners with GenScript on GenCircle dsDNA Development
•
Shandong Boan Biotechnology Co., Ltd, a controlling subsidiary of China-based Luye Pharma Group (HKG: 2186), has entered into a strategic partnership with GenScript Biotech Corporation (HKG: 1548), a leading Contract Research Organization (CRO). The collaboration aims to develop and manufacture the small circular double-stranded DNA vector GenCircle dsDNA, which is…
-
Betta Pharmaceuticals and EyePoint Pharmaceuticals Submit EYP-1901 for NMPA Review
•
China’s Betta Pharmaceuticals (SHE: 300558) has announced that the clinical trial filing for its EYP-1901 intravitreal implant, co-filed with EyePoint Pharmaceuticals, Inc (NASDAQ: EYPT), has been accepted for review by the National Medical Products Administration (NMPA). The drug is intended to be assessed as a potential treatment for pathological myopia…
-
NMPA Releases 68th Batch of Reference Drugs for Generic Quality Consistency Evaluation
•
The National Medical Products Administration (NMPA) has released the 68th batch of reference drugs for generic quality consistency evaluation (GQCE) work, marking a significant step in ensuring the quality and consistency of generic drugs. This batch includes 41 new specifications, highlighting the NMPA’s ongoing commitment to enhance the standards of…
-
Basecare Medical to Acquire BMX Holdco for $40 Million, Expanding IVF Portfolio
•
China-based in vitro fertilization (IVF) specialist, Suzhou Basecare Medical Co., Ltd (HKG: 2170), has announced its intention to acquire 100% stakes in Singapore-headquartered BMX Holdco Pte. Ltd for a sum of $40 million. The acquisition will see BMX becoming a wholly-owned subsidiary of Basecare upon deal closure. BMX Holdco Pte.…
-
Nona Biosciences Partners with PharmaEssentia for Harnessing Harbor Mice Technology
•
Nona Biosciences, a wholly owned subsidiary of Harbour BioMed (HKG: 2142), has announced a strategic partnership with PharmaEssentia Corp.’s R&D center in Boston, United States. The collaboration will fully utilize Nona Bio’s Harbor Mice whole human transgenic mouse platform technology for biomedicine research and development, marking a significant step in…
-
First Condor Biotechnology Secures Tens of Millions in Pre-Series A Financing for CAR-T Cell Trials
•
First Condor Biotechnology, a Guangdong-based cell therapy developer, has reportedly secured tens of millions of renminbi in a Pre-Series A financing round. This funding round was led by Guangdong Lianjing Investment Group, marking a significant step forward for the company. The proceeds from this investment will be directed towards the…
-
China’s NHC and 13 Bureaus Launch Campaign to Rectify Pharmaceutical and Medical Services Practices
•
The National Health Commission (NHC) along with 13 other bureaus has jointly released a notification titled “Key Points for Correcting Unhealthy Practices in the Field of Pharmaceutical Procurement/Sales and Medical Services in 2023”. This notice marks the first work deployment following the adjustment of the “Member units of the Interministerial…
-
Bayer Q1 2023 Financial Report: Sales Dip Amid Regional Challenges and COVID-19 Impact
•
Germany-based Bayer (ETR: BAYN) has released its financial report for the first quarter of 2023, revealing a 1.1% decrease in group sales, excluding exchange effects, to €14.389 billion (USD 15.74 billion). Net profits fell 33.8% year-on-year (YOY) to €2.178 billion, reflecting the ongoing challenges in the pharmaceutical industry. Pharmaceuticals Unit…
